Gut-Brain Axis Highlights At Dubai Microbiome Symposium On Health Innovation

Dubai is set to host the Microbiome Revolution Symposium on 5th February 2026, bringing global attention to microbiome science. The meeting will gather experts, clinicians, innovators, investors and policymakers. They will examine how gut–brain axis research is changing approaches to prevention, mental health and personalised medicine. The theme, ‘Unlocking the Gut–Brain Axis for the Future of Health’, reflects this broad scientific focus.

Researchers now describe the gut–brain–microbiome axis as a bidirectional network. Signals move between the brain and gut microbiome through neural, hormonal and immune routes. This framework is shaping new thinking about long-term disease risk, stress, mood disorders and digestive conditions. The Dubai event aims to translate these insights into clinical models and health strategies relevant across regions.

The Microbiome Revolution Symposium programme will highlight leading figures in microbiome science and clinical innovation. Sessions will feature case studies, translational research and discussion on regulation and investment. Delegates will explore how microbiome-based approaches might support earlier diagnostics, targeted therapies and integrated mental health services. The agenda is designed to connect scientific findings with real-world healthcare systems and policy choices.

Professor Sarkis Mazmanian of the California Institute of Technology will be among the keynote speakers. The MacArthur Fellow has shown how gut microbes and their metabolites can alter immune signalling. Professor Sarkis Mazmanian’s work links microbial activity to neuroinflammation associated with neurological disease. These findings have supported new lines of inquiry into conditions such as Parkinson’s disease and autism spectrum disorders.

Clinical practice will also be in focus through the work of Dr Laurie Keefer of the Icahn School of Medicine at Mount Sinai. Dr Laurie Keefer is recognised for psychobehavioral research and brain–gut behavioural therapies. These approaches combine psychological tools with medical care for chronic digestive disorders. Professor Ted Dinan of University College Cork will add perspectives on ‘psychobiotics’, connecting microbiome, nutrition and mental health.

The wider vision for the event was outlined by Tushar Singhvi, Deputy CEO and Head of Investments at Crescent Enterprises, who said, "Some of the most meaningful advances in healthcare will come not from isolated breakthroughs, but from understanding interconnected systems. The gut–brain axis is emerging as one of the most promising frontiers – opening new pathways in prevention, mental health, and personalised care – and enabling more integrated, impactful solutions." The symposium in Dubai is positioned as a platform to discuss these linked scientific, clinical and investment trends in one forum.

With inputs from WAM